I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Damia, Giovanna
186
results:
Search for persons
X
Format
Online (186)
Mediatypes
Articles (Online) (90)
Bookchapter (Online) (1)
OpenAccess-fulltext (95)
Sorted by: Relevance
Sorted by: Year
?
1
Onvansertib treatment overcomes olaparib resistance in high..:
Chiappa, Michela
;
Decio, Alessandra
;
Guarrera, Luca
...
Cell Death & Disease. 15 (2024) 7 - p. , 2024
Link:
https://doi.org/10.1038/..
?
2
BRCA1 foci test as a predictive biomarker of olaparib respo..:
Guffanti, Federica
;
Mengoli, Ilaria
;
Alvisi, Maria Francesca
...
Frontiers in Pharmacology. 15 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
3
Overview of BH3 mimetics in ovarian cancer:
Del Bufalo, Donatella
;
Damia, Giovanna
Cancer Treatment Reviews. 129 (2024) - p. 102771 , 2024
Link:
https://doi.org/10.1016/..
?
4
Different Patterns of Platinum Resistance in Ovarian Cancer..:
Chiappa, Michela
;
Guffanti, Federica
;
Grasselli, Chiara
...
International Journal of Molecular Sciences. 25 (2024) 5 - p. 3049 , 2024
Link:
https://doi.org/10.3390/..
?
5
Epithelioid Mesothelioma Patients with Very Long Survival D..:
Ganzinelli, Monica
;
Guffanti, Federica
;
Ianza, Anna
...
Cancers. 15 (2023) 17 - p. 4309 , 2023
Link:
https://doi.org/10.3390/..
?
6
Bcl-2 family inhibitors sensitize human cancer models to th..:
Valentini, Elisabetta
;
Di Martile, Marta
;
Brignone, Matteo
...
Cell Death & Disease. 14 (2023) 7 - p. , 2023
Link:
https://doi.org/10.1038/..
?
7
The ATR inhibitor elimusertib exhibits anti‐lymphoma activi..:
Sartori, Giulio
;
Tarantelli, Chiara
;
Spriano, Filippo
...
British Journal of Haematology. 204 (2023) 1 - p. 191-205 , 2023
Link:
https://doi.org/10.1111/..
?
8
Exploiting endocytosis for transfection of mRNA for cytopla..:
Gustà, Muriel F.
;
Edel, Michael J.
;
Salazar, Vivian A.
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
9
Tolerability of Eribulin and correlation between polymorphi..:
La Verde, Nicla
;
Damia, Giovanna
;
Garrone, Ornella
...
Breast Cancer Research. 24 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
10
Onvansertib and paclitaxel combined in platinum-resistant o..:
Affatato, Roberta
;
Chiappa, Michela
;
Guffanti, Federica
...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592210950 , 2022
Link:
https://doi.org/10.1177/..
?
11
Present and Future Perspective on PLK1 Inhibition in Cancer..:
Chiappa, Michela
;
Petrella, Serena
;
Damia, Giovanna
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
12
Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Inc..:
Chilà, Rosaria
;
Chiappa, Michela
;
Guffanti, Federica
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
13
The disruption of the CCDC6 – PP4 axis induces a BRCAness l..:
Morra, Francesco
;
Merolla, Francesco
;
Damia, Giovanna
...
Journal of Experimental & Clinical Cancer Research. 41 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
14
Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib..:
Chiappa, Michela
;
Guffanti, Federica
;
Anselmi, Martina
...
Cancers. 14 (2022) 7 - p. 1807 , 2022
Link:
https://doi.org/10.3390/..
?
15
CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilitie..:
Sauta, Elisabetta
;
Reggiani, Francesca
;
Torricelli, Federica
...
Cancers. 13 (2021) 14 - p. 3477 , 2021
Link:
https://doi.org/10.3390/..
1-15